NASDAQ:ACHL
Achilles Therapeutics plc
- Stock
locale
United Kingdom
market
STOCKSindustry
Biotechnologywebsite
www.achillestx.comipo date
Mar 31, 2021
Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for us...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus